Mucosal-associated invariant T (MAIT
MR1-Restricted V␣19i Mucosal-Associated Invariant T Cells Are Innate T Cells in the Gut

M ucosal-associated invariant T (MAIT)
3 cells are a phylogenetically conserved population of T cells defined by the expression of an invariant TCR␣ chain that was originally identified during repertoire analysis of human CD4 Ϫ CD8 Ϫ double-negative (DN) peripheral blood ␣␤ T cells (1) . Lantz and colleagues (2) demonstrated that this TCRV␣7.2-J␣33 chain (V␣7.2i) is expressed on a subset of human T cells and a homologous TCRV␣19-J␣33 (V␣19i) chain on a similar T cell population in mice and cattle. Using quantitative PCR and limiting dilution assays, they determined that ϳ1 of 7.5 DN and 1 of 50 CD8␣␣ ϩ T cells from human PBLs express V␣7.2i, whereas 1 of 56 of DN T cells from the mesenteric lymph nodes (mLN) express the V␣19i chain in mice; in cattle, the majority of V␣19i T cells appear to be DN. Approximately 1 of 6000 of these cells is estimated to be CD4 ϩ in humans, whereas a higher proportion appears to express CD4 in mice. Both human and murine MAIT cell TCR␣ chains preferentially associate with a limited number of TCR␤ chains. V␣19i T cells are not present in nude mice, indicating that they develop in the thymus. In addition, they require B cells for selection/expansion, and the few IgA ϩ cells present in MT Ϫ/Ϫ mice are sufficient for this (3) . Most intriguingly, V␣19i T cells are most frequent in the intestinal lamina propria (LP) and are not present in germfree mice (3) , which suggests that they require commensal flora to expand and/or persist. When possible, these observations have been confirmed with human V␣7.2i T cells, indicating that MAIT cells are a conserved lineage of T cells that function in the gut mucosa. How MAIT cells recognize and respond to commensal flora is not known, but their restriction element has been identified: V␣19i T cells require the MHC class I-related molecule MR1 for selection/expansion (3). The most striking feature of MR1 is the remarkable conservation of its ␣1 and ␣2 domains among mammalian species; human and mouse MR1 share 90% (␣1)/89% (␣2) sequence identity, whereas other functionally equivalent nonclassical and classical MHC molecules share 51-78% (␣1)/41-76% (␣2) (4, 5) . This implies a highly conserved function for MR1, perhaps binding an invariant ligand. Supporting this, cumulative evidence from experiments with transfectants indicates that MR1 protein does not reach the cell surface in the absence of ligand (6, 7) . In addition, studies with MAIT cell hybridomas and a panel of MR1 mutants strongly suggest that V␣19i T cells recognize MR1 in a ligand-dependent manner (8) . MAIT cells are present in TAP Ϫ/Ϫ mice, indicating that the putative ligand is not a conventional peptide. Certainly, products derived from or induced by commensal flora are highly plausible candidates for MR1 ligands, although ubiquitously expressed endogenous ligands appear to activate MAIT cell hybridomas (8) .
MAIT cells most closely resemble another phylogenetically conserved population of T cells that also express an invariant TCR␣ chain in association with a limited number of TCR␤ chains. A unique TCRV␣24-J␣18 chain and its homologous TCRV␣14-J␣18 murine counterpart are expressed on functionally analogous human and murine T cell subsets generally referred to as NK T cells because most coexpress NK cell receptors, including NK1.1 or NKR-P1A (CD161) (9 -11) . V␣24/14i NK T cells recognize the MHC class Ib molecule CD1d in association with hydrophobic ligands, including the lysosomal glycosphingolipid, isoglobotrihexosylceramide, as well as glycosphingolipids from the cell walls of Gram-negative bacteria that do not contain LPS (12) (13) (14) . Upon TCR ligation, V␣24i/14i NK T cells rapidly secrete a number of cytokines, including large amounts of IL-4 and IFN-␥, and have increased cytolytic activity. They have been implicated in antibacterial, antiviral, and antiprotozoan responses as well as tumor rejection. In addition, V␣14i NK T cells provide protection against several autoimmune diseases, including diabetes and experimental autoimmune encephalomyelitis, and can induce tolerance (9 -11) . However, they also mediate uncontrolled Th2 responses with pathological consequences, including asthma and ulcerative colitis (15) (16) (17) . In summary, V␣24i/14i NK T cells are a distinct lineage of innate T cells that respond rapidly to TCR stimulation and thereby influence the adaptive response in a variety of ways (18) .
Given their similarities, it is tempting to speculate that MAIT cells and V␣24i/14i NK T cells play similar roles but in different environments: V␣24/14i NK T cells in internal organs, including the thymus, bone marrow (BM), liver, and spleen, and MAIT cells in the gut and possibly other mucosal tissues. However, this has been difficult to test because MAIT cells are rare, comprising ϳ10% of DN T cells in the gut LP and Յ2% of DN ␣␤ T cells in the mLN of wild-type (WT) mice, and analysis has been limited to relatively indirect molecular methods. Therefore, to create a model in which these cells are more abundant, we generated transgenic mice expressing the conserved TCR␣ chain (V␣19i) characteristic of MAIT cells. 
Materials and Methods
Mice
To generate V␣19i transgenic mice, we amplified a DNA fragment containing the canonical rearranged V␣19-J␣33 MAIT cell junction using a nested set of oligonucleotides located 5Ј of the V␣19 leader sequence and 3Ј of J␣33 and genomic DNA isolated from a sample enriched for DN ␣␤TCR ϩ cells as a template. Previous experiments demonstrated that Ͼ90% of V␣19-J␣33 junctions amplified from this DNA carry the canonical MAIT cell junction (3). The 1.1-kb PCR fragment was cloned and sequenced. A plasmid containing the correct rearrangement and no PCRinduced errors was cloned into the TCR␣ expression vector developed by D. Mathis and C. Benoist (Harvard University, Boston, MA) (19) . A purified fragment free of vector sequence was injected into C57BL/6 one-cell 
a Lymphocytes from V␣19i transgenic and control mice were stained as noted and the percentages of individual subsets determined by flow cytometry. Data are presented as mean Ϯ SD. n.d., not done.
embryos by the Department of Pathology and Immunology Transgenic/ Knockout Core Facility at Washington University. We obtained two founders, one carrying 2 (V␣19i 2 ) and one carrying Ͼ10 (V␣19i 10 ) copies of the transgene. Both were bred to C␣ Ϫ/Ϫ C57BL/6 (B6) mice (B6.129S2-Tcra tm1Mom /J; The Jackson Laboratory) and MR1 Ϫ/Ϫ mice, which have been described (3). The MR1 Ϫ/Ϫ mice used for these studies had been backcrossed to B6 mice for 10 generations. Mice were typed by Southern blot for the TCR␣ mutation and PCR for the V␣19i transgenes and MR1 deletion. All animal studies were approved by the Washington University School of Medicine Animal Studies Committee.
Isolation of cells
Thymus, spleen, and mLN cell suspensions were prepared by mechanical disruption of tissues. Intraepithelial lymphocytes (IEL) and LP lymphocytes (LPL) were isolated from the small intestine. Briefly, intestines were excised at the stomach and the cecum and flushed with PBS; after Peyer's patches were removed, they were opened longitudinally and washed in HBSS. The intestines were then cut into small fragments and shaken vigorously in 100 ml of HBSS with 2 mM DTT (Sigma-Aldrich) for 30 min at 37°C. The cell suspensions were passed through a 70-m cell strainer and centrifuged, and IEL were isolated on 30 -70% discontinuous Percoll gradients. The tissue fragments were incubated for an additional 30 min, shaking at 37°C in HBSS with 1 mM DTT and 5 mM EDTA, and the remaining IEL/enterocytes were discarded. The remaining tissue was incubated in 20 ml of DMEM/5% BCS (HyClone) with 0.1 mg/ml DNase I (Roche) and 35 g/ml Liberase Blenzymes 3 (Roche) for 20 -30 min at 37°C and filtered through a 70-m cell strainer, and LPL were isolated on 30 -70% Percoll gradients.
Flow cytometry and cell sorting
The following mAbs were purchased from BD Pharmingen: anti-TCR␣␤ (H57-597), anti-TCR␥␦ (GL3), anti-V␤2TCR (B20.6), anti-V␤4TCR
, and anti-CD25 (7D4). Anti-ICOS (15F9) mAb was purchased from eBioscience. Cell suspensions were stained using a combination of Abs conjugated to TriColor, FITC, PE, and allophycocyanin (or biotin followed by allophycocyanin-conjugated streptavidin) (Molecular Probes), and analyzed on a FACScan with CellQuest software (BD Biosciences). Dead cells were excluded by propidium iodide gating. T cell subsets were sorted as indicated in the figures from spleen and mLN using a MoFlo cytometer (DakoCytomation). Analysis of sorted cells confirmed Ն95% purity.
Cytokine secretion
Cells were cultured at the indicated density for 24 -72 h at 37°C with 5% CO 2 in 100 l of RPMI 1640 medium containing 10% BCS (HyClone) in 96-well plates that had been coated overnight at 4°C with the indicated concentrations of anti-CD3⑀ (145-2C11 or KT3) and anti-CD28 (37.51) mAbs (BD Pharmingen). Supernatants were assayed for IFN-␥, TNF-␣, IL-5, IL-4, IL-2, IL-10, IL-6, MCP-1, and IL-12p70 using cytometric bead arrays included in the mouse inflammation and mouse Th1/Th2 cytokine kits (BD Pharmingen) according to the manufacturer's instructions.
Intracellular detection of cytokines
Cells were stimulated with plate-bound anti-CD3⑀ (145-2C11) and anti-CD28 (37.51) mAbs (BD Pharmingen) for 48 h. PMA (10 Ϫ7 M; SigmaAldrich) and ionomycin (0.8 g/ml; Sigma-Aldrich) were added for the last 6 h and monensin (2 M; Sigma-Aldrich) for the last 4 h of stimulation. Cells were stained for cell surface markers before fixation with 2% formaldehyde for 15 min. Cells were washed and then permeabilized with saponin (0.5%; Sigma-Aldrich) for intracellular staining with the following FITC-and allophycocyanin-labeled mAb as indicated: anti-IFN-␥-FITC (XMG1.2), anti-IL10-allophycocyanin (JES5-16E3), and anti-IL4-allophycocyanin (11B11) (BD Pharmingen).
Results
MR1-restricted V␣19i transgenic T cells recapitulate what is known about endogenous MAIT cells
We obtained two V␣19i transgenic founders, one carrying 2 (V␣19i 2 ) and one carrying Ͼ10 (V␣19i 10 ) copies of the transgene.
Both founders were bred to C␣ Ϫ/Ϫ B6 and MR1 Ϫ/Ϫ B6 mice to generate V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ and V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ mice; all data shown are from mice on these backgrounds. The low-and high-copy mice had very similar phenotypes, and the subtle differences noted are probably due to higher expression of the transgene in the V␣19i 10 mice. Total thymocyte numbers were reduced ϳ40% in the low-copy-number and 60% in the high-copy-number V␣19i transgenic mice, compared with B6 controls (Table I) . Total spleen cell numbers also were reduced, and the peripheral lymph nodes were Ͻ25% of WT size in both lines of V␣19i transgenic mice, whereas the mLN were of normal size and cellularity. T cell frequency was reduced ϳ2-fold in the mLN and spleens of both transgenic lines, compared with WT mice. However, T cell frequency and numbers were similar in the thymus, mLN, spleen, and IEL of V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ and V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ animals, and a slight increase in T cell frequency was observed in the intestinal LP of V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice (Table I ). To identify T cells dependent on MR1 for development, we compared T cell subsets in the thymus, mLN, spleen, IEL, and LP of V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ and V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice. Thymii from all transgenic mice had an increased proportion of DN and very few CD4 ϩ or CD8 ϩ single-positive T cells (Fig. 1A) ; the majority of TCR␤ high thymocytes were DN in these mice (Fig. 1B , Table I ). Because an aberrant population of mature DN T cells develops in most TCR␣ transgenic mice due to premature expression of the transgene, this was not unexpected (20, 21) . Table I. backgrounds 
MR1
Ϫ/Ϫ and C␣
backgrounds as well as WT controls (Fig. 2) . A slight increase in the frequency of CD4 high T cells expressing V␤6 and V␤8.1/2 was seen in V␣19i transgenic mice on an MR1
ϩ background, and differences between MR1
Ϫ/Ϫ and MR1 ϩ mice were more evident in the V␣19i 10 line (Fig. 2B ). An increase in the frequency of CD8 ϩ T cells expressing V␤8.1/2 was evident only in the high-copynumber V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice, and the frequency of V␤6 ϩ CD8 ϩ T cells was slightly higher in both V␣19i transgenic lines on MR1 ϩ/ϩ vs MR1 Ϫ/Ϫ backgrounds (Fig. 2C) . Much more striking, the frequency of DN/CD4 low T cells expressing either V␤6 or V␤8.1/2 in both high-and low-copy V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice was double that observed in V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ mice (Fig. 2D ). In MR1-deficient transgenic mice, 23-25% of mLN DN/CD4 low T cells expressed V␤6 or V␤8.1/2, whereas 47-51% of this population expressed one of these three TCR␤ chains in MR1 ϩ/ϩ mice ( Fig. 2D and Table II ). This skewing also was evident in DN/ CD4 low T cells from the thymus and spleen and was more pronounced in those isolated from the LP of V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice (Table II) . In summary, MR1-restricted V␣19i transgenic T cells recapitulate much of what is known about endogenous MAIT cells: they are primarily DN or CD4 low ; preferentially express V␤8.1, V␤8.2, or V␤6; and are more frequent in the gut LP. Therefore, these V␣19i transgenic mice provide a valid model for further characterization of MAIT cell development and function.
MR1-restricted V␣19i T cells have an NK T cell phenotype
Given the parallels between MAIT and V␣24/14i NK T cells, we assessed NK1.1 expression on T cells from V␣19i transgenic mice. Indeed, a high proportion of TCR␤ ϩ cells expressed NK1.1 in V␣19iC␣ (Fig.  3A) . Six to 9% of TCR␤ ϩ cells from the mLN and 11-15% from the spleen of V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice expressed NK1.1; 20 -30% of V␣19i transgenic T cells in the LP were NK1.1 ϩ (Fig. 3A and Table I ). In the spleen and mLN, the majority of V␣19i 
NK1.1
ϩ T cells were DN (60 -80%), and the remaining were either CD4 low (10 -30%) or CD8 low (10%). A slightly higher proportion expressed CD8 in the LP (data not shown). As expected, the majority of MR1-restricted NK1.1 ϩ V␣19i T cells expressed either V␤6 or V␤8.1/2 (Table II) .
To cells from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice share this phenotype as do most NK1.1 ϩ T cells from B6 mice. High levels of CD25 are characteristic of T regulatory cells (Treg) dependent on the transcription factor FoxP3 (22) . Although MR1-restricted V␣19i T cells express low levels of CD25, they do not express FoxP3 as determined by RT-PCR of RNA from sorted cells (data not shown). ICOS is associated with IL-10 production (23) and may reflect encounter with self ligand; for instance, ICOS is expressed on naive DO11.1 transgenic T cells specific for OVA 323-339 from mice expressing high levels of OVA under control of the rat insulin promoter (24) . Overall, these data are consistent with the observation that human MAIT cells have an activated/memory phenotype (2) and, furthermore, demonstrate that a T cell population phenotypically similar to V␣14i NK T cells develops in V␣19i transgenic mice on an MR1 ϩ/ϩ (but not MR1 Ϫ/Ϫ ) background and that 25-50% of this population expresses NK1.1.
Transgenic MAIT cells secrete IFN-␥, IL-4, IL-5, and IL-10 following TCR ligation
We initially assessed T cell proliferation in response to platebound anti-CD3 or anti-CD3 and anti-CD28 mAbs in bulk cultures from spleen and/or mLN and found that T cells from V␣19iC␣
ϩ/ϩ mice proliferated poorly in comparison to those from V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ and WT mice (data not shown). We then measured cytokine secretion from V␣19iC␣
Ϫ/Ϫ MR1 ϩ/ϩ , and control mLN and splenic T cells after 24 -72 h of culture with plate-bound anti-CD3 with or without anti-CD28. Although all T cells secreted IFN-␥, and TNF-␣, we detected significant amounts of IL-4, IL-5, and IL-10 in supernatants from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ but not V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ or B6 mice (Fig. 4A) . Conversely, more IL-2 was detected in supernatants from V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ and B6 T cells than from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ T cells. Very similar results were obtained with LPL in these assays; again, only those isolated from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice secreted significant amounts of IL-4, IL-5, and IL-10; in contrast, IELs from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ secreted IL-4 and IL-10 but very little IL-5. (Fig. 4B) . We repeated these experiments with sorted T cells from spleen and/or mLN and found that only the V␤8.1/8.2/6 ϩ DN/CD4 low T cell population from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice secreted significant levels of IL-4, IL-5, and IL-10 following TCR ligation (Fig. 5) . These data were confirmed by staining mLN or splenic T cells for intracellular cytokines following TCR ligation. Only T cells from V␣19iC␣
ϩ/ϩ mice secreted IL-4 and IL-10, and we were able to detect a small population secreting both IFN-␥ and IL-4 and another IFN-␥ and IL-10 (Fig. 6) .
IL-4, IL-5, and IFN-␥ secretion following TCR ligation in vitro is characteristic of V␣14i NK T cells. In this respect, MR1-restricted V␣19i T cells appear functionally analogous to CD1d-restricted V␣14i NKT cells. To further test this, we injected V␣19i transgenic mice with an anti-CD3 mAb; rapid secretion of IL-4 and IFN-␥ following in vivo activation with anti-CD3 in the absence of further stimulation is a hallmark of NK T cell function (25) . Ninety minutes after i.v. injection of an anti-CD3 mAb, splenocytes from V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice secreted high levels of IL-4 and IFN-␥, whereas splenocytes from identically treated V␣19iC␣ Ϫ/Ϫ MR1 Ϫ/Ϫ mice secreted very little of these cytokines (Fig. 7) . This indicates that, like V␣14i NK T cells, MR1-restricted V␣19i transgenic T cells rapidly secrete IL-4 and IFN-␥ following CD3 ligation in vivo. Cumulatively, these data demonstrate that at least a proportion of MR1-restricted transgenic MAIT cells are functionally equivalent to V␣14i NK T cells. ϩ double-positive cells in the thymus (26) . Interestingly, functional NK T cells also can develop in transgenic mice expressing TCRs specific for MHC class Ia or class II/peptide in the absence of endogenous TCRV␣ rearrangements (27) (28) (29) . This suggests that selection of NK T cells does not require V␣14i and CD1d per se. Given this, generation of V␣19i transgenic NK1.1 ϩ T cells probably reflects this mode of selection, which is clearly favored in mice expressing MR1. Consistent with this, Shimamura and Huang (30) reported that ϳ50% of T cell hybridomas established from NK1.1 ϩ T cells from CD1d Ϫ/Ϫ mice express the V␣19i MAIT invariant TCR␣ chain. In addition, the frequency of NK1.1 ϩ T cells in the V␣19i transgenic mice is similar to that seen in transgenic mice expressing a V␣14i TCR␣ chain driven by a V␣ promoter and Ig enhancer (31) .
How do MAIT cells fit in with the known NK T cell subsets in WT mice?
Eight-five percent of murine NK T cells express V␣14i; almost all thymic and liver NK T cells are CD1d dependent and express the V␣14i chain, whereas CD1d-and thymus-independent NKT cells are enriched in the spleen and BM (9 -11) . Extensive repertoire analysis of DN NK T cells from the spleen and BM revealed two distinct populations: one strikingly skewed toward V␣14, V␤7, V␤8.1/2/3, and V␤2 (V␣14i NK T cells), and the other with an essentially unbiased TCRV␣ and -V␤ repertoire (32) . This indicates that V␣19i T cells do not comprise a significant proportion of the V␣14i-negative NK1.1 ϩ T cell population in the spleen and BM of normal mice. This is not surprising, given that MAIT cells are detected primarily in the gut LP. The large population of NK1.1 ϩ T cells residing in the LP of V␣19iC␣ Ϫ/Ϫ MR1 ϩ/ϩ mice may correspond to a functionally significant population of T cells in the LP of WT mice. In addition, the few NK1. (34, 35) . In both cases, the IL-10-secreting NK T cells were critical for inducing or recruiting Treg. MR1-restricted V␣19i transgenic T cells more closely resemble Treg induced by encounter with self Ag in the periphery; for example, DO11.1 transgenic T cells specific for OVA 323-339 isolated from mice expressing high levels of OVA under control of the rat insulin promoter secrete IL-10 after in vitro activation, as do T cells from transgenic mice expressing a TCR specific for a peptide epitope of glutamic acid decarboxylase 65 (24, 36) . V␣14i NK T cells have the capacity to secrete Th1 and/or Th2 cytokines depending on their mode of stimulation. It is quite possible that MAIT cells share this phenotype, and what we have observed are different aspects of MAIT cell differentiation. However, clearly, the capacity to secrete IL-10 is favored more by V␣19i/MR1 than by V␣14i/CD1d interactions in naive mice
The main differences between MAIT cells and V␣14i NK T cells are their restriction elements and anatomical location. V␣14i NK T cells are most frequent in internal organs, including the thymus, liver, BM, and spleen, and recognize endogenous and exogenous glycosphingolipids bound to CD1d; unlike MAIT cells, they are present in germfree mice (37) . MAIT cells accumulate primarily in the gut LP and mLN and are dependent on MR1 and commensal flora for selection/expansion. They may be present in other mucosal tissues and have been reported to accumulate in some of the CNS lesions of multiple sclerosis patients as well as in peripheral nerve samples from patients with chronic inflammatory demyelinating polyneuropathy (38) . It is probable that they recognize MR1 in the context of several related ligands, some of which are likely to be derived from or induced by commensal flora. Our data demonstrate that V␣19i MAIT cells are phenotypically and functionally very similar to NK T cells and, hence, may influence the gut and perhaps other immune responses in a variety of ways, depending on their mode of stimulation. In addition, at least a proportion of these cells are primed for IL-10 production. As MAIT cells are relatively rare, even in the gut LP, one of their primary roles may be to induce or recruit other Treg, as has been shown for V␣14i NK T cells. The V␣19i transgenic mice clearly illustrate the striking parallels between V␣19i MAIT cells and V␣14i NK T cells and provide a valuable model for further probing MAIT cell function as well as a possible means to identify MR1 ligands.
